Merrimack Pharmaceuticals, Inc.
MACK
$0.02
Change (1 day)
$15.89
Year High
$11.53
Year Low
Categories
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
P/B ratio for Merrimack Pharmaceuticals, Inc. (MACK)
P/B ratio as of 2023: 10.23
According to Merrimack Pharmaceuticals, Inc.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 10.23. At the end of 2022 the company had a P/B ratio of 8.05.
P/B ratio history for Merrimack Pharmaceuticals, Inc. from 2009 to 2023
P/B ratio at the end of each year
| Year | P/B ratio |
|---|---|
| 2023 | 10.23 |
| 2022 | 8.05 |
| 2021 | 3.70 |
| 2020 | 5.76 |
| 2019 | 2.43 |
| 2018 | 0.69 |
| 2017 | 1.11 |
| 2016 | -1.60 |
| 2015 | -3.76 |
| 2014 | -9.09 |
| 2013 | -9.54 |
| 2012 | -53.55 |
| 2011 | -1.51 |
| 2010 | -0.25 |
| 2009 | -0.28 |